Paul J. Tesar
- Developmental Neuroscience top 0.5%
- Neurogenesis and neuroplasticity mechanisms 18
- Molecular Biology top 1%
- Pluripotent Stem Cells Research 28
- CRISPR and Genetic Engineering 17
- Renal and related cancers 11
- Epigenetics and DNA Methylation 8
- Genomics and Chromatin Dynamics 7
- RNA Research and Splicing 7
- Cancer Research top 5%
- MicroRNA in disease regulation 13
- Genetics top 2%
- Aging top 5%
- Co-authors
- Ronald D.G. McKayJosh ChenowethFrances A. BrookRichard L. GardnerE.P. EvansDavid L. MackT. J. DaviesPeter C. Scacheri
- Partner nations
- United StatesDenmarkUnited Kingdom
In The Last Decade
Paul J. Tesar
64 papers receiving 6.1k citations
Hit Papers
Peers
Comparison fields: 5 of 119
- Developmental Neuroscience 609
- Molecular Biology 5.3k
- Cancer Research 580
- Genetics 385
- Aging 56
Countries citing papers authored by Paul J. Tesar
This map shows the geographic impact of Paul J. Tesar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Paul J. Tesar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Paul J. Tesar more than expected).
Fields of papers citing papers by Paul J. Tesar
This network shows the impact of papers produced by Paul J. Tesar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Paul J. Tesar. The network helps show where Paul J. Tesar may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Paul J. Tesar, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 13 | |
| 2 | 2024 | 24 | |
| 3 | 2021 | 9 | |
| 4 | 2021 | 41 | |
| 5 | 2020 | 33 | |
| 6 | 2018 | 240 | |
| 7 | 2016 | 8 | |
| 8 | 2014 | 113 | |
| 9 | High Throughput and High Content Screening Capabilities of the University of Cincinnati Drug Discovery Center | 2013 | 0 |
| 10 | 2012 | 69 | |
| 11 | 2012 | 71 | |
| 12 | 2011 | 408 | |
| 13 | 2011 | 114 | |
| 14 | 2010 | 38 | |
| 15 | 2010 | 193 | |
| 16 | 2010 | 24 | |
| 17 | 2010 | 15 | |
| 18 | 2009 | 14 | |
| 19 | 2008 | 168 | |
| 20 | 2007 | 176 |
About Paul J. Tesar
Paul J. Tesar is a scholar working on Developmental Neuroscience, Cancer Research and Molecular Biology, having authored 65 papers that have together received 6.2k indexed citations. Recurring topics across this work include Pluripotent Stem Cells Research (28 papers), Neurogenesis and neuroplasticity mechanisms (18 papers), CRISPR and Genetic Engineering (17 papers), MicroRNA in disease regulation (13 papers), Renal and related cancers (11 papers), Epigenetics and DNA Methylation (8 papers), Genomics and Chromatin Dynamics (7 papers) and RNA Research and Splicing (7 papers). The work is most often cited by research in Developmental Neuroscience (609 citations), Molecular Biology (5.3k citations) and Cancer Research (580 citations). Paul J. Tesar has collaborated with scholars based in United States, Denmark and United Kingdom. Frequent co-authors include Ronald D.G. McKay, Josh Chenoweth, Frances A. Brook, Richard L. Gardner, E.P. Evans, David L. Mack, T. J. Davies, Peter C. Scacheri, Gabriel E. Zentner and Daniel C. Factor. Their work appears in journals such as Nature, Science and Cell.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.